XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Oct. 26, 2024
Oct. 28, 2023
Cash flows from operating activities    
Net income $ 56,657 $ 55,620
Adjustments to reconcile net income to cash provided by operating activities    
Loss on disposal and impairment of assets 40 559
Gain on sale of investments (113) (1,136)
Provision for doubtful accounts 477 44
Depreciation and amortization 23,644 25,092
Amortization of right-of-use lease assets 41,817 37,285
Lease impairment/(settlement) 0 (1,175)
Equity-based compensation expense 9,047 7,337
Change in deferred taxes 2,377 (340)
Change in receivables 10,000 (9,843)
Change in inventories (22,625) 9,757
Change in other assets (9,626) (1,361)
Change in payables 12,380 (4,040)
Change in lease liabilities (42,721) (38,121)
Change in other liabilities (13,101) (22,802)
Net cash provided by operating activities 68,253 56,876
Cash flows from investing activities    
Proceeds from disposals of assets 176 4,037
Capital expenditures (32,769) (26,501)
Purchases of investments (5,317) (17,485)
Proceeds from sales of investments 10,225 21,956
Acquisitions (17,841) (7,311)
Net cash used for investing activities (45,526) (25,304)
Cash flows from financing activities    
Payments on finance lease liabilities (291) (206)
Holdback payments for acquisitions 0 (5,000)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 9,887 (1,859)
Repurchases of common stock (53,144) (20,014)
Dividends paid to shareholders (16,731) (15,632)
Dividends paid to minority interest joint venture partners [1] (1,414) (1,172)
Net cash used for financing activities (61,693) (43,883)
Effect of exchange rate changes on cash and equivalents 930 (900)
Change in cash, cash equivalents and restricted cash (38,036) (13,211)
Cash, cash equivalents and restricted cash at beginning of period 341,098 346,678
Cash, cash equivalents and restricted cash at end of period 303,062 333,467
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 4,420 $ 3,079
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.